Work

Phase II Study of Rituximab Given in Conjunction with Standard Chemotherapy in Primary Central Nervous System Lymphoma (PCNSL)[E1F05]

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.1530.1530

Authors: Lode J. Swinnen, Anne O'Neill, Philip H Imus, Sachin Gujar, David Schiff, Lawrence Kleinberg, Ranjana Advani, Erin Dunbar, Dennis F. Moore, Stuart Grossman

Institutions: Johns Hopkins University, Harvard University, Dana-Farber/Harvard Cancer Center, Johns Hopkins Hospital, University of Virginia, Stanford Medicine, Stanford University, University of Florida, Cancer Center of Kansas

Language: English

Topic: CNS Lymphoma Diagnosis and Treatment

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2526392872

FWCI:

Cites:

Cited by:

Related to: 10